3

OWNERSHIP DOCUMENT

Company: Polaryx Therapeutics, Inc.
Filed: January 29, 2026
Period of Report: January 29, 2026
Accession Number: 0001213900-26-009565

View Document ↗ View on SEC.gov ↗